BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Connor S, Barron E, Redhead D, Ireland H, Madhavan K, Parks R, Garden O. Palliation for suspected unresectable hilar cholangiocarcinoma. European Journal of Surgical Oncology (EJSO) 2007;33:341-5. [DOI: 10.1016/j.ejso.2006.11.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Kariya CM, Wach MM, Ruff SM, Ayabe RI, Lo WM, Torres MB, Petrick JL, McNeel TS, Davis JL, McGlynn KA, Hernandez JM. Postbiliary drainage rates of cholangitis are impacted by procedural technique for patients with supra-ampullary cholangiocarcinoma: A SEER-Medicare analysis. J Surg Oncol 2019;120:249-55. [PMID: 31044430 DOI: 10.1002/jso.25485] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Boškoski I, Tringali A, Familiari P, Bove V, Landi R, Attili F, Perri V, Onder G, Mutignani M, Costamagna G. A 17 years retrospective study on multiple metal stents for complex malignant hilar biliary strictures: Survival, stents patency and outcomes of re-interventions for occluded metal stents. Dig Liver Dis 2019;51:1287-93. [PMID: 31036471 DOI: 10.1016/j.dld.2019.03.032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
3 Buettner S, Wilson A, Margonis GA, Gani F, Ethun CG, Poultsides GA, Tran T, Idrees K, Isom CA, Fields RC, Krasnick B, Weber SM, Salem A, Martin RC, Scoggins CR, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, Maithel SK, Pawlik TM. Assessing Trends in Palliative Surgery for Extrahepatic Biliary Malignancies: A 15-Year Multicenter Study. J Gastrointest Surg 2016;20:1444-52. [PMID: 27121233 DOI: 10.1007/s11605-016-3155-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
4 Soares KC, Kamel I, Cosgrove DP, Herman JM, Pawlik TM. Hilar cholangiocarcinoma: diagnosis, treatment options, and management. Hepatobiliary Surg Nutr. 2014;3:18-34. [PMID: 24696835 DOI: 10.3978/j.issn.2304-3881.2014.02.05] [Cited by in F6Publishing: 59] [Reference Citation Analysis]
5 Gomez D, Patel P, Lacasia-purroy C, Byrne C, Sturgess R, Palmer D, Fenwick S, Poston G, Malik H. Impact of specialized multi-disciplinary approach and an integrated pathway on outcomes in hilar cholangiocarcinoma. European Journal of Surgical Oncology (EJSO) 2014;40:77-84. [DOI: 10.1016/j.ejso.2013.10.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
6 Tan LB, Madhavan K, Chang SK. Intrahepatic segment V biliary enteric bypass. ANZ J Surg 2014;84:885-6. [PMID: 24171909 DOI: 10.1111/ans.12329] [Reference Citation Analysis]
7 Mishreki AP, Lim E, Cranefield P, Pascoe S, Jackson S, Stell DA. Low rate of active treatment of patients with hilar cholangiocarcinoma. Ann R Coll Surg Engl 2013;95:349-52. [PMID: 23838498 DOI: 10.1308/003588413X13629960046598] [Reference Citation Analysis]
8 Ruys AT, van Haelst S, Busch OR, Rauws EA, Gouma DJ, van Gulik TM. Long-term survival in hilar cholangiocarcinoma also possible in unresectable patients. World J Surg. 2012;36:2179-2186. [PMID: 22569746 DOI: 10.1007/s00268-012-1638-5] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
9 Matull WR, Dhar DK, Ayaru L, Sandanayake NS, Chapman MH, Dias A, Bridgewater J, Webster GJ, Bong JJ, Davidson BR, Pereira SP. R0 but not R1/R2 resection is associated with better survival than palliative photodynamic therapy in biliary tract cancer. Liver Int 2011;31:99-107. [PMID: 20846273 DOI: 10.1111/j.1478-3231.2010.02345.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 2.8] [Reference Citation Analysis]
10 Bi AH, Zeng ZC, Ji Y, Zeng HY, Xu C, Tang ZY, Fan J, Zhou J, Zeng MS, Tan YS. Impact factors for microinvasion in intrahepatic cholangiocarcinoma: a possible system for defining clinical target volume. Int J Radiat Oncol Biol Phys 2010;78:1427-36. [PMID: 20378269 DOI: 10.1016/j.ijrobp.2009.09.069] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
11 Kozarek RA. Inflammation and carcinogenesis of the biliary tract: update on endoscopic treatment. Clin Gastroenterol Hepatol 2009;7:S89-94. [PMID: 19896106 DOI: 10.1016/j.cgh.2009.08.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
12 Park J, Kim MH, Kim KP, Park DH, Moon SH, Song TJ, Eum J, Lee SS, Seo DW, Lee SK. Natural History and Prognostic Factors of Advanced Cholangiocarcinoma without Surgery, Chemotherapy, or Radiotherapy: A Large-Scale Observational Study. Gut Liver. 2009;3:298-305. [PMID: 20431764 DOI: 10.5009/gnl.2009.3.4.298] [Cited by in Crossref: 113] [Cited by in F6Publishing: 126] [Article Influence: 8.7] [Reference Citation Analysis]
13 Paik WH, Park YS, Hwang J, Lee SH, Yoon CJ, Kang S, Lee JK, Ryu JK, Kim Y, Yoon YB. Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach. Gastrointestinal Endoscopy 2009;69:55-62. [DOI: 10.1016/j.gie.2008.04.005] [Cited by in Crossref: 171] [Cited by in F6Publishing: 140] [Article Influence: 13.2] [Reference Citation Analysis]
14 Garcea G, Ong SL, Dennison AR, Berry DP, Maddern GJ. Palliation of Malignant Obstructive Jaundice. Dig Dis Sci 2009;54:1184-98. [DOI: 10.1007/s10620-008-0479-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]